Two years working as President of a chain of community pharmacies was all the exposure Eric needed to know something was very wrong with our prescription drug supply chain. Eric left in July 2018 and formed 46brooklyn Research (www.46brooklyn.com) to explore the disturbing complexity of our country’s prescription supply chain. 46brooklyn Research freely shares its work with the public through interactive data visualizations designed to make it easier for users to learn from public drug pricing and utilization databases, and original research that dives deep into the inner workings of the supply chain.
Eric has 17 years of experience across a wide variety of technical and management roles on both “Wall Street” and “Main Street.” He has worked within, invested in, and studied dozens of industries over his professional career – and in Eric’s opinion, this one is by far the most complicated.
Eric graduated from University of Florida in 2001 with a BS in Chemical Engineering, and obtained an MBA from Harvard Business School in 2008.
Learn more about the our Crossroads 2020 Speakers!
As a reporter who didn't start covering pharma until 2016, I really appreciated this great roundup of important drug approvals of last decade, from @adamfeuerstein n @matthewherper